- Investing Ideas
- /
- Global Solid Balance Sheet and Fundamentals
Global Solid Balance Sheet and Fundamentals
UPDATED Apr 04, 2024
High return on equity, past performance and sound balance sheet.
1,997 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
300893 | CN¥29.19 | -1.0% | 22.4% | CN¥6.6b | CN¥34.50 | PE33.3x | E27.4% | 0.3% | Automobiles | ||
IMI | UK£18.10 | -0.3% | 27.0% | UK£4.7b | UK£20.22 | PE19.8x | E11.9% | 1.6% | Capital Goods | ||
TCU | S$0.93 | 1.6% | -5.1% | S$214.3m | S$1.20 | PE21.8x | E8.4% | 4.3% | Commercial Services | ||
526951 | ₹1,636.85 | 5.0% | 53.3% | ₹27.7b | ₹2,078.50 | PE23.6x | E22.9% | 0.2% | Capital Goods | ||
6600 | HK$17.96 | 12.0% | 69.4% | HK$10.9b | HK$17.86 | PE9x | E4.7% | 0% | Pharmaceuticals & Biotech | ||
PIDILITIND | ₹2,997.80 | -0.6% | 28.5% | ₹1.5t | ₹2,745.00 | PE89.1x | E14.9% | 0.4% | Materials | ||
MPL | AU$3.69 | -1.9% | 7.6% | AU$10.3b | AU$3.86 | PE14.8x | E-1.3% | 4.2% | Insurance | ||
ERNT | €212.00 | -0.9% | -8.2% | €281.1m | €205.23 | PE12.7x | E2.3% | 2.8% | Tech | ||
4716 | JP¥11,005.00 | -3.9% | 20.3% | JP¥1.4t | JP¥11,428.57 | PE25.4x | E5.3% | 1.5% | Software | ||
A067160 | ₩114,900.00 | -2.4% | 42.2% | ₩1.2t | ₩135,473.68 | PE16.5x | E15.3% | 0.7% | Media | ||
SIG | US$106.04 | 6.0% | 47.3% | US$4.6b | US$122.30 | PE6.1x | E-10.9% | 1.1% | Retail | ||
A042700 | ₩136,300.00 | 1.9% | 566.5% | ₩13.3t | ₩86,333.33 | PE49.4x | E-18.9% | 0.3% | Semiconductors | ||
ADYEN | €1,543.00 | -1.6% | 8.7% | €47.9b | €1,623.87 | PE68.6x | E19.9% | n/a | Diversified Financials | ||
G5EN | kr126.80 | -2.4% | -41.8% | kr1.0b | kr238.33 | PE8x | E6.4% | 6.3% | Media | ||
1211 | HK$197.90 | -1.8% | -13.0% | HK$624.8b | HK$292.85 | PE17.7x | E14.6% | 1.7% | Automobiles | ||
2006 | CN¥14.47 | -3.4% | -37.1% | CN¥6.5b | CN¥18.50 | PE23.4x | S31.0% | 1.4% | Capital Goods | ||
CONCORDBIO | ₹1,513.65 | -0.5% | n/a | ₹158.4b | ₹1,596.80 | PE52x | E23.8% | 0% | Pharmaceuticals & Biotech | ||
QNBA | ج.م32.40 | 1.2% | 84.4% | ج.م69.8b | ج.م44.75 | PB1x | E18.3% | 2.3% | Banks | ||
2276 | HK$8.10 | -4.8% | 62.3% | HK$3.6b | HK$14.92 | PE9.8x | E17.2% | 2.7% | Healthcare | ||
2517 | CN¥11.35 | 3.0% | -19.1% | CN¥24.2b | CN¥16.84 | PE21.6x | E24.5% | 1.8% | Media | ||
META | US$510.92 | 5.2% | 136.4% | US$1.3t | US$526.03 | PE33.3x | E14.3% | 0.4% | Media | ||
4482 | JP¥751.00 | -8.4% | 35.6% | JP¥16.0b | n/a | PE30.7x | E11.5% | 1.5% | Software | ||
SHRIPISTON | ₹2,063.15 | 5.2% | 264.7% | ₹90.9b | ₹2,421.00 | PE21.9x | E16.4% | 0.2% | Automobiles | ||
DRMA | Rp1,050.00 | -1.9% | 23.5% | Rp4.9t | Rp1,825.00 | PE8.1x | E9.9% | 2.0% | Automobiles |